Concepedia

Zheng-lu Wang

ZW

Statistics

Publications

5

Citations

131

H-Index

5

Active since

2016

Affiliations

Tianjin First Center Hospital(Current)

Tianjin Medical University

Chinese Academy of Medical Sciences & Peking Union Medical College

Nankai University

National Health and Family Planning Commission

Zheng-lu Wang is an author at Tianjin First Center Hospital specializing in oncology, capecitabine-based therapy, and pharmacology.

ORCID

Publications per year

2016–2023

5

Publications

5

Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation

Donghui Guo, Dongsheng Gu, Honghai Wang et al. · European Journal of Radiology · 2019 · 81 citations

, , +17

Capecitabine Regulates HSP90AB1 Expression and Induces Apoptosis via Akt/SMARCC1/AP‐1/ROS Axis in T Cells

Sai Zhang, Shunli Fan, Zheng-lu Wang et al. · Oxidative Medicine and Cellular Longevity · 2022 · 16 citations · Full text

, , +17

Metronomic capecitabine with rapamycin exerts an immunosuppressive effect by inducing ferroptosis of CD4+ T cells after liver transplantation in rat

Hao Wang, Ruining Yang, Zheng-lu Wang et al. · International Immunopharmacology · 2023 · 12 citations · Full text

, , +17

The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone

Qingqing Li, Jing Wang, Zheng-lu Wang et al. · Biomedicine & Pharmacotherapy · 2023 · 12 citations · Full text

, , +17

Clonal Origin of Hepatocellular Carcinoma and Recurrence After Liver Transplantation

Zheng-lu Wang, Weihua Gong, Dawei Shou et al. · Annals of Transplantation · 2016 · 10 citations · Full text

, , +17

1–5 of 5